https://pharm-atlas.com/blog/arni-sovmestimost-preparatov/ 2026-03-26T10:22:22+00:00 https://pharm-atlas.com/blog/arni-preparaty-pokazaniya/ 2026-03-26T10:22:04+00:00 https://pharm-atlas.com/blog/lechenie-gerpesa-pri-immunodeficite/ 2026-03-26T10:19:43+00:00 https://pharm-atlas.com/blog/targetnaya-terapiya-raka-zhkt/ 2026-03-26T10:17:21+00:00 https://pharm-atlas.com/blog/udalenie-podoshvennykh-borodavok/ 2026-03-26T10:16:35+00:00 https://pharm-atlas.com/blog/statiny-mify-i-pravda/ 2026-03-26T10:15:13+00:00 https://pharm-atlas.com/blog/kak-pogoda-vliyayut-na-davlenie/ 2026-03-26T10:14:25+00:00 https://pharm-atlas.com/blog/ingibitory-lechenie-ateroskleroza/ 2026-03-26T10:13:10+00:00 https://pharm-atlas.com/blog/podderzhivayushchaya-terapiya-vzk/ 2026-03-26T10:12:22+00:00 https://pharm-atlas.com/blog/recidiviruyushchiy-kandidoz-chto-eto/ 2026-03-26T10:09:57+00:00 https://pharm-atlas.com/blog/lechenie-vich-pervye-shagi-posle-diagnosa/ 2026-03-26T10:08:55+00:00 https://pharm-atlas.com/blog/kak-umenshit-tyagu-k-alkogolyu/ 2026-03-26T10:08:14+00:00 https://pharm-atlas.com/blog/kak-borotsya-s-alkogolnoy-zavisimostyu/ 2026-03-26T10:04:07+00:00 https://pharm-atlas.com/blog/ponizhennaya-kislotnost-zheludka/ 2026-03-26T10:00:51+00:00 https://pharm-atlas.com/blog/standartnaya-terapiya-vich/ 2026-03-26T09:58:20+00:00 https://pharm-atlas.com/blog/kak-prohodit-lechenie-citostatikami/ 2026-03-26T09:57:16+00:00 https://pharm-atlas.com/blog/citostatiki-chto-eto-i-chem-otlichayutsya/ 2026-03-26T09:51:41+00:00 https://pharm-atlas.com/blog/arni-pri-serdechnoy-nedostatochnosti/ 2026-03-26T09:45:58+00:00 https://pharm-atlas.com/blog/evolyuciya-statinov/ 2026-03-19T13:11:23+00:00 https://pharm-atlas.com/blog/svoystva-gipolipidemicheskih-preparatov/ 2026-03-17T13:40:29+00:00 https://pharm-atlas.com/blog/statiny-poslednego-pokoleniya/ 2026-03-17T13:27:32+00:00 https://pharm-atlas.com/blog/infekcii-pri-immunosupressii/ 2026-03-16T12:08:41+00:00 https://pharm-atlas.com/blog/immunosupressivnye-i-immunomodulyatory/ 2026-03-13T08:44:06+00:00 https://pharm-atlas.com/blog/immunosupressory-chto-eto-i-pokazaniya/ 2026-03-12T13:04:10+00:00 https://pharm-atlas.com/blog/fda-odobrilo-peksidartinib-dly-lecheniy-teno-sinovialnoy-gigantokletochnoy-opuholi/ 2026-03-05T08:58:11+00:00 https://pharm-atlas.com/blog/fda-prisvoil-preparatu-niraparib-status-proryvnoy-terapii/ 2026-03-05T08:52:29+00:00 https://pharm-atlas.com/blog/kombinacia-preparatov-nivolymaba-y-ipilimymaba/ 2026-03-05T08:46:53+00:00 https://pharm-atlas.com/blog/daratumumab-novye-perspektivy-lecheniy-mnojestvennoy-mielomy/ 2026-03-05T08:41:58+00:00 https://pharm-atlas.com/blog/mify-i-fakty-ob-onkologii/ 2026-03-05T08:33:14+00:00 https://pharm-atlas.com/blog/preparaty-pri-jepilepsii-chto-vajno-znat/ 2026-03-03T09:49:42+00:00 https://pharm-atlas.com/blog/nehodjkinskay-limfoma-u-detey/ 2026-03-03T09:32:36+00:00 https://pharm-atlas.com/blog/vesennyy-allergiy-kak-vybrat-lekarstva/ 2026-03-03T09:20:10+00:00 https://pharm-atlas.com/blog/jelezodefi-itnay-anemiy-u-vzroslyh/ 2026-03-03T08:18:29+00:00 https://pharm-atlas.com/blog/visokiy-saxar-v-krovi/ 2026-03-02T14:05:26+00:00 https://pharm-atlas.com/blog/kak-povysit-muzhskoye-zdorovye/ 2026-03-02T13:56:18+00:00 https://pharm-atlas.com/blog/kak-spravitsya-s-animiey/ 2026-03-02T13:49:04+00:00 https://pharm-atlas.com/blog/kak-pravilno-prinimat-antibiotik/ 2026-03-02T13:38:19+00:00 https://pharm-atlas.com/blog/preparaty-v-lechenii-raka-prostaty/ 2026-02-26T12:02:01+00:00 https://pharm-atlas.com/blog/venetoklaks-demonstriruet-jeffektivnost-v-lechenii-nehodjkinskoy-limfomy/ 2026-02-26T11:58:28+00:00 https://pharm-atlas.com/blog/v-ssha-odobren-novyy-preparat-dly-lecheniy-hronicheskogo-limfo-itarnogo-leykoza/ 2026-02-26T11:57:29+00:00 https://pharm-atlas.com/blog/kachestvo-zhizni-pri-rake-kishechnika/ 2026-02-26T11:53:25+00:00 https://pharm-atlas.com/blog/defitsit-reparatsii-dnk/ 2026-02-26T11:51:57+00:00 https://pharm-atlas.com/blog/ingibitory-pcsk9-snizhenie-holesterina/ 2026-02-26T11:51:11+00:00 https://pharm-atlas.com/blog/rastitelnye-uspokoitelnye-sredstva/ 2026-02-26T11:50:10+00:00 https://pharm-atlas.com/blog/faktory-vozniknoveniya-insulta/ 2026-02-26T11:45:44+00:00 https://pharm-atlas.com/blog/povyshenie-davleniya-posle-40/ 2026-02-26T11:34:30+00:00 https://pharm-atlas.com/news/konsultatsiya-so-spetsialistami/ 2026-02-26T11:30:59+00:00 https://pharm-atlas.com/blog/lecheniye-melanomy-dabrafenibom-s-trametinibom/ 2026-02-26T11:29:22+00:00 https://pharm-atlas.com/blog/digoksina-s-trametinibom-pri-lechenii-metastaticheskoj-melanomy/ 2026-02-26T11:28:06+00:00 https://pharm-atlas.com/blog/metody-lecheniya-epilepsii/ 2026-02-26T11:21:40+00:00 https://pharm-atlas.com/blog/abirateron-vs-enzalutamid-rak-prostaty/ 2026-02-25T10:22:19+00:00 https://pharm-atlas.com/blog/pobochnye-effekty-statinov-i-metody-borby/ 2026-02-24T10:16:25+00:00 https://pharm-atlas.com/blog/fda-odobril-primenenie-rozlytrek-dly-lecheniy-neskolkih-vidov-raka/ 2026-02-18T07:57:39+00:00 https://pharm-atlas.com/blog/letrozol-i-tamoksifen-dly-mujskogo-pola-kak-pravilno-prinimat-v-bodibildinge-i-drugie-momenty/ 2026-02-18T07:56:20+00:00 https://pharm-atlas.com/blog/v-csha-odobreno-novoe-pokazanie-k-primeneniy-pembrolizymaba/ 2026-02-18T07:54:31+00:00 https://pharm-atlas.com/blog/avelumab-dly-lecheniy-kar-inomy-merkely/ 2026-02-18T07:53:18+00:00 https://pharm-atlas.com/blog/brigatinib-novye-vozmojnosti-v-lechenii-refrakternogo-k-krizotinibu-nemelkokletochnogo-raka-legkogo/ 2026-02-18T07:51:57+00:00 https://pharm-atlas.com/blog/keytruda-jeffektivna-u-pa-ientok-s-metastaticheskim-troynym-otri-atelnym-rakom-molochnoy-jelezy/ 2026-02-18T07:50:59+00:00 https://pharm-atlas.com/blog/kombincia-preparatov-neratinib-s-kepcitabinom/ 2026-02-18T07:48:35+00:00 https://pharm-atlas.com/blog/linparza-deystvuet-v-2-raza-jeffektivnee-chem-standartnay-himioterapiy/ 2026-02-18T07:47:19+00:00 https://pharm-atlas.com/blog/sochetanie-nivolumaba-i-ipilimumaba-pri-melanome-uluchshaet-vyzhivaemost/ 2026-02-18T07:46:13+00:00 https://pharm-atlas.com/blog/opublikovany-novye-dannye-po-jeffektivnosti-vysokih-doz-gliveka/ 2026-02-18T07:44:55+00:00 https://pharm-atlas.com/blog/trastyzymab-dly-terapii-raka-molochnoy-zhelezy/ 2026-02-18T07:43:29+00:00 https://pharm-atlas.com/blog/panitumumab-vo-2-j-linii-lecheniya-pri-nemelkokletochnym-rake-legkogo-povyshaet-vyzhivaemost/ 2026-02-18T07:40:25+00:00 https://pharm-atlas.com/blog/ehffektivnost-vorinostata-s-bevacizumabom-pri-svetlokletochnom-pochechno-kletochnym-rake/ 2026-02-18T07:39:11+00:00 https://pharm-atlas.com/blog/pembrolizumab-ehffektivnee-himioterapii-pri-platino-ustojchivoj-urotelialnoj-karcinome/ 2026-02-18T07:38:06+00:00 https://pharm-atlas.com/blog/beva-izumab-demonstriruet-mnogoobeschauschie-rezultaty-v-lechenii-pochechnoy-kar-inomy/ 2026-02-18T07:36:54+00:00 https://pharm-atlas.com/blog/blinatumomab-prevzoshel-po-jeffektivnosti-himioterapiu-v-lechenii-ostrogo-limfoblastnogo-leykoza/ 2026-02-18T07:35:59+00:00 https://pharm-atlas.com/news/v-ssha-odobrili-pembrolizumab-dly-lecheniy-limfomy-hodjkina/ 2026-02-18T07:35:06+00:00 https://pharm-atlas.com/news/polza-linparza-pri-rake-molochnoj-zhelezy-s-mutaciej-v-genah-brca/ 2026-02-17T08:25:51+00:00 https://pharm-atlas.com/news/fda-odobrilo-nivolumab-dly-lecheniy-urotelialnoy-kar-inomy/ 2026-02-17T08:24:37+00:00 https://pharm-atlas.com/blog/izrailskiy-preparat-glivek-demonstriruet-dolgosrochnuu-jeffektivnost-v-lechenii-leykemii/ 2026-02-17T08:21:13+00:00 https://pharm-atlas.com/blog/pembrolizumab-demonstriruet-jeffektivnost-v-lechenii-melanomy-slizistyh-obolochek/ 2026-02-17T08:20:10+00:00 https://pharm-atlas.com/blog/kabozantinib-pri-lechenii-raka-prostaty/ 2026-02-17T08:15:59+00:00 https://pharm-atlas.com/blog/imatinib-uluchshaet-dolgosrochnuu-vyjivaemost-bolnyh-s-gastrointestinalnymi-stromalnymi-opuholymi/ 2026-02-17T08:14:33+00:00 https://pharm-atlas.com/blog/pazopanib-povyshaet-vyjivaemost-pa-ientov-s-jembrionalnymi-opuholymi-ustoychivymi-k-himioterapii/ 2026-02-17T08:13:02+00:00 https://pharm-atlas.com/blog/pembrolizumab-i-nivolumab-nazvany-glavnymi-dostijeniymi-v-borbe-s-melanomoy-za-2017-god/ 2026-02-17T08:11:51+00:00 https://pharm-atlas.com/blog/dobavlenie-mabtery-k-himioterapii-uluchshaet-rezultaty-lecheniy-pojilyh/ 2026-02-17T08:10:30+00:00 https://pharm-atlas.com/blog/nia-in-snijaet-riski-ploskokletochnoy-kar-inomy/ 2026-02-17T08:04:39+00:00 https://pharm-atlas.com/blog/bevacizumab-k-himioterapii-pri-melkokletochnom-rake-legkih-uluchshaet-vyzhivaemost/ 2026-02-17T08:02:59+00:00 https://pharm-atlas.com/blog/terapevticheskay-gipotermiy-pomogaet-oslabit-neyrotoksicheskie-jeffekty-paklitaksela/ 2026-02-17T08:01:53+00:00 https://pharm-atlas.com/blog/sochetanie-bortezomiba-s-himioterapiey-pri-limfoblastnom-leicoze/ 2026-02-17T08:01:02+00:00 https://pharm-atlas.com/blog/pembrolizumab-uluchshaet-obschuu-vyjivaemost-bolnyh-urotelialnym-rakom/ 2026-02-17T07:59:23+00:00 https://pharm-atlas.com/blog/ibrutinib-perspektiven-v-lechenii-refrakternoy-k-rituksimabu-makroglobulinemii-valdenstrema/ 2026-02-16T06:38:54+00:00 https://pharm-atlas.com/blog/ehffektivnost-docetaksela-pri-kastracionno-rezistentnym-rake-prostaty/ 2026-02-16T06:37:47+00:00 https://pharm-atlas.com/blog/vyyvlen-novyy-pobochnyy-jeffekt-iksabepilona/ 2026-02-16T06:36:31+00:00 https://pharm-atlas.com/blog/godovay-terapiy-kape-itabinom-u-pa-ientov-s-rakom-tolstoy-kishki-yvlyetsy-bezopasnoy/ 2026-02-16T06:35:14+00:00 https://pharm-atlas.com/blog/ruksolitinib-uluchshaet-sostoynie-pa-ientov-s-hronicheskim-limfoleykozom/ 2026-02-16T06:32:20+00:00 https://pharm-atlas.com/blog/ehffektivnost-ipilimumaba-s-pegilirovannym-interferonom-pri-neoperabelnoj-melanome/ 2026-02-16T06:31:12+00:00 https://pharm-atlas.com/blog/ehribulin-demonstriruet-shodnuu-aktivnost-s-dakarbazinom-u-pa-ientov-s-leyomiosarkomoy/ 2026-02-16T06:29:46+00:00 https://pharm-atlas.com/blog/issledovaniy-podtverdili-blagopriytnyy-profil-bezopasnosti-nivolumaba-pri-lechenii-melanomy/ 2026-02-16T06:27:46+00:00 https://pharm-atlas.com/blog/lechenie-preparatom-kapesitibionom-pri-negativnom-rake-molochnoy-zhelezy/ 2026-02-16T06:27:10+00:00 https://pharm-atlas.com/blog/ehffektivnost-atezolizumaba-u-pacientov-s-metastaticheskim-uroterialnym-rakom/ 2026-02-16T06:25:28+00:00 https://pharm-atlas.com/bez-rubriki/osimertinib-ili-preparat-platiny/ 2026-02-16T06:24:14+00:00 https://pharm-atlas.com/blog/sorafenib-s-vinorelbinom-pri-metastaticheskom-rake-molochnoj-zhelezy/ 2026-02-16T06:22:04+00:00 https://pharm-atlas.com/blog/nemelkokletochnyy-rak-legkogo-atezolizumab-prevoshodit-po-jeffektivnosti-do-etaksel/ 2026-02-16T06:21:01+00:00 https://pharm-atlas.com/blog/__trashed/ 2026-02-16T06:14:59+00:00 https://pharm-atlas.com/blog/kombina-iy-beva-izumaba-i-taksana-jeffektivna-pri-metastaticheskom-rake-molochnoy-jelezy/ 2026-02-13T09:18:22+00:00 https://pharm-atlas.com/blog/rak-jeludka-primenenie-trastuzumaba-uluchshaet-pokazateli-vyjivaemosti/ 2026-02-13T09:17:28+00:00 https://pharm-atlas.com/blog/nivolumab-v-issledovanii-fazy-iii/ 2026-02-13T09:12:13+00:00 https://pharm-atlas.com/blog/trastuzumab-s-lapatinibom-lecheniye-raka-molochnoy-zhelezy/ 2026-02-13T09:10:47+00:00 https://pharm-atlas.com/blog/neoaduvantnay-jendokrinnay-terapiy-pri-er-pozitivnom-rake-grudi-bolee-jeffektivna-chem-himioterapiy/ 2026-02-13T09:09:32+00:00 https://pharm-atlas.com/blog/kombina-iy-palbo-ikliba-s-letrazolom-podtverdila-svou-jeffektivnost-u-jenschin-s-rasprostranennym-rmj/ 2026-02-13T09:06:55+00:00 https://pharm-atlas.com/blog/lecheniy-melanomy-dabrafeniba-s-trametinibom/ 2026-02-13T09:04:05+00:00 https://pharm-atlas.com/news/dobavlenie-beva-izumaba-k-pervoy-linii-terapii/ 2026-02-13T09:02:58+00:00 https://pharm-atlas.com/blog/v-ssha-razreshili-primenyt-opdivo-dly-lecheniy-raka-golovy-i-shei/ 2026-02-13T09:00:00+00:00 https://pharm-atlas.com/blog/kabozantinib-pri-nelechenom-metastaticheskom-pochechno-kletochnym-rake-uluchshaet-vyzhivaemost/ 2026-02-13T08:54:18+00:00 https://pharm-atlas.com/blog/uchenye-opredelili-biomarkery-pozvolyuschie-o-enit-jeffektivnost-lecheniy-pembrolizumabom/ 2026-02-13T08:52:58+00:00 https://pharm-atlas.com/blog/ehffektivnost-nivolumab-pri-recidive-ili-metastazami-raka-golovy-i-shei/ 2026-02-13T08:51:40+00:00 https://pharm-atlas.com/blog/aduvantnay-terapiy-ipilimumabom-povyshaet-vyjivaemost-pri-melanome/ 2026-02-13T08:50:32+00:00 https://pharm-atlas.com/blog/pembrolizumab-jeffektiven-v-kachestve-pervoy-linii-lecheniy-nmrl/ 2026-02-13T08:47:02+00:00 https://pharm-atlas.com/blog/dobavlenie-kselody-k-standartnoy-himioterapii-uluchshaet-rezultaty-lecheniy-raka-molochnoy-jelezy/ 2026-02-13T08:36:34+00:00 https://pharm-atlas.com/blog/gozerelina-y-himiopreparatov-s-tamoksifenom/ 2026-02-12T07:02:23+00:00 https://pharm-atlas.com/blog/fda-izmenilo-rejim-vvedeniy-preparata-opdivo/ 2026-02-12T07:01:35+00:00 https://pharm-atlas.com/blog/lechenie-preparatom-daklinza-i-sovaldi/ 2026-02-12T06:59:39+00:00 https://pharm-atlas.com/blog/na-rynke-mojet-poyvitsy-novyy-preparat-dly-lecheniy-gormonozavisimogo-raka-molochnoy-jelezy/ 2026-02-12T06:58:36+00:00 https://pharm-atlas.com/blog/kombina-iy-am0010-c-pembrolizumabom-povyshaet-jeffektivnost-lecheniy-nekotoryh-vidov-raka/ 2026-02-12T06:58:00+00:00 https://pharm-atlas.com/blog/pegilirovannyy-filgrastim-demonstriruet-svou-jeffektivnost-i-bezopasnost/ 2026-02-12T06:56:55+00:00 https://pharm-atlas.com/blog/avastin-sobludayte-pravila-hraneniy-i-transportirovki/ 2026-02-12T06:55:51+00:00 https://pharm-atlas.com/blog/aduvantnay-terapiy-tamoksifenom-i-ingibitorami-aromatazy-snijaet-riski-kontralateralnogo-raka-grudi/ 2026-02-12T06:54:28+00:00 https://pharm-atlas.com/blog/lechenie-blinatumomabom-doljno-provoditsy-pod-kontrolem-multidis-iplinarnoy-gruppy-spe-ialistov/ 2026-02-12T06:52:55+00:00 https://pharm-atlas.com/blog/rezultaty-primeneniy-beva-izumaba-v-realnoy-praktike-soglasuutsy-s-dannym-klinicheskih-issledovaniy/ 2026-02-12T06:51:52+00:00 https://pharm-atlas.com/blog/sorafenib-odinakovo-pomogaet-pa-ientam-vseh-vozrastov/ 2026-02-12T06:50:51+00:00 https://pharm-atlas.com/blog/revlimid-i-rityksan-pri-lechenii-limfy/ 2026-02-12T06:49:56+00:00 https://pharm-atlas.com/blog/lechenie-tamoksifenom-ne-privodit-k-raku-jendometriy/ 2026-02-12T06:48:37+00:00 https://pharm-atlas.com/blog/geneksol-rm-podtverdil-jeffektivnost-v-lechenii-raka-molochnoy-jelezy/ 2026-02-12T06:46:55+00:00 https://pharm-atlas.com/blog/novye-dannye-podtverjdaut-jeffektivnost-primeneniy-kombina-ii-opdivo-i-ervoy-pri-melanome/ 2026-02-12T06:44:50+00:00 https://pharm-atlas.com/blog/priem-keytrudy-pri-melanome-v-menshey-stepeni-uhudshaet-kachestvo-jizni-chem-provedenie-himioterapii/ 2026-02-11T06:53:18+00:00 https://pharm-atlas.com/blog/afatinib-i-gefitinib/ 2026-02-11T06:52:23+00:00 https://pharm-atlas.com/blog/rituksimab-jeffektiven-pri-v-kletochnyh-ostryh-limfoblastnyh-leykozah/ 2026-02-11T06:51:10+00:00 https://pharm-atlas.com/blog/bevacizumab-pri-rake-molochnoj-zhelezy-uluchshaet-rezultaty-lecheniya/ 2026-02-11T06:50:18+00:00 https://pharm-atlas.com/blog/ipilimumab-karboplatin-etopozid-pri-melkokletochnym-rake-legkogo/ 2026-02-11T06:49:22+00:00 https://pharm-atlas.com/blog/ehffektivnost-kadsila-pri-progressiruyushchem-rake-molochnoj-zhelezy/ 2026-02-11T06:47:59+00:00 https://pharm-atlas.com/blog/kejtruda-pri-melanome-ili-nemelkokletochnom-rake-legkogo/ 2026-02-11T06:46:51+00:00 https://pharm-atlas.com/blog/kobimetinib-s-vemurafenibom-pri-melanome-s-mutaciej-braf-v600-uluchshaet-vyzhivaemost/ 2026-02-11T06:43:13+00:00 https://pharm-atlas.com/blog/trastuzumab-pri-rannej-stadii-her2-pozitivnom-rake-molochnoj-zhelezy-povyshaet-vyzhivaemost/ 2026-02-11T06:42:17+00:00 https://pharm-atlas.com/blog/kombina-iy-beva-izumaba-s-jerlotinibom-povyshaet-jeffektivnost-lecheniy-raka-legkogo/ 2026-02-11T06:41:03+00:00 https://pharm-atlas.com/blog/v-es-skoro-odobryt-dva-novyh-preparata-protiv-gepatita-s/ 2026-02-11T06:40:12+00:00 https://pharm-atlas.com/blog/nivolumab-spravlyetsy-s-lecheniem-raka-pochki-luchshe-chem-jeverolimus/ 2026-02-11T06:34:58+00:00 https://pharm-atlas.com/blog/regorafenib-uluchshaet-vyjivaemost-bolnyh-rakom-pecheni/ 2026-02-11T06:32:29+00:00 https://pharm-atlas.com/blog/ehffektivnost-nivolumaba-pri-rake-pochki/ 2026-02-11T06:30:56+00:00 https://pharm-atlas.com/blog/novoe-ustroystvo-pomojet-vovremy-diagnostirovat-zabolevaniy-sheyki-matki/ 2026-02-11T06:29:22+00:00 https://pharm-atlas.com/blog/nivolumab-jeffektiven-v-terapii-ploskokletochnogo-raka-golovy-i-shei/ 2026-02-10T10:18:13+00:00 https://pharm-atlas.com/blog/v-ssha-odobren-preparat-kabometiks-dly-lecheniy-raka-pochki/ 2026-02-10T10:16:52+00:00 https://pharm-atlas.com/blog/geneticheski-modifi-irovannyy-virus-novoe-sredstvo-lecheniy-v-onkologii/ 2026-02-10T10:15:01+00:00 https://pharm-atlas.com/blog/aspirin-mojet-uvelichit-jiznesposobnost-onkologicheskih-bolnyh/ 2026-02-10T10:10:23+00:00 https://pharm-atlas.com/blog/odobren-fda-preparat-defitelio/ 2026-02-10T10:09:27+00:00 https://pharm-atlas.com/blog/preimushchestva-ehntresto-pri-hronicheskoj-serdechnoj-nedostatochnosti/ 2026-02-10T10:07:48+00:00 https://pharm-atlas.com/blog/snijeny-eny-na-preparaty-opdivo-i-tafinlar/ 2026-02-10T10:06:17+00:00 https://pharm-atlas.com/blog/opdivo-mojet-s-uspehom-naznachatsy-pa-ientam-s-metastaticheskim-rakom-pochki/ 2026-02-10T10:04:40+00:00 https://pharm-atlas.com/blog/novye-uspehi-v-lechenii-her2-polojitelnogo-raka-molochnoy-jelezy/ 2026-02-10T10:03:25+00:00 https://pharm-atlas.com/blog/s-2017-goda-v-rossii-mojet-byt-razreshena-onlayn-prodaja-farmpreparatov/ 2026-02-10T10:02:23+00:00 https://pharm-atlas.com/blog/v-ssha-odobrena-kombina-iy-preparatov-opdivo-i-ervoy/ 2026-02-10T09:59:49+00:00 https://pharm-atlas.com/blog/fda-odobrilo-pervyy-preparat-sposobnyy-uvelichivat-prodoljitelnost-jizni-bolnyh-s-liposarkomoy/ 2026-02-10T09:58:15+00:00 https://pharm-atlas.com/blog/novye-dannye-o-preparate-olizio/ 2026-02-10T09:57:10+00:00 https://pharm-atlas.com/blog/ehverolimus-odobren-v-ssha-dly-lecheniy-neyrojendokrinnyh-opuholey/ 2026-02-10T09:55:59+00:00 https://pharm-atlas.com/blog/chto-vybrat-originalnyy-preparat-ili-djenerik/ 2026-02-10T09:53:23+00:00 https://pharm-atlas.com/blog/msd-rasskajet-o-poslednih-rezultatah-issledovaniy-primeneniy-pembrolizumaba/ 2026-02-09T09:19:16+00:00 https://pharm-atlas.com/blog/strong-leykoz-u-podrostkov-i-detey-strong/ 2026-02-09T09:17:11+00:00 https://pharm-atlas.com/blog/razovay-doza-trastuzumaba-vyzyvaet-zametnyy-immunnyy-otvet-pri-nekotoryh-formah-raka-grudi/ 2026-02-09T09:16:03+00:00 https://pharm-atlas.com/blog/prichiny-detskoy-onkologii/ 2026-02-09T09:13:18+00:00 https://pharm-atlas.com/blog/profilaktika-grippa-i-orvi-jetoy-zimoy/ 2026-02-09T09:12:32+00:00 https://pharm-atlas.com/blog/profilaktika-razvitiy-saharnogo-diabeta/ 2026-02-09T09:11:45+00:00 https://pharm-atlas.com/blog/strong-melanoma-prichiny-simptomy-lechenie-strong/ 2026-02-09T09:10:54+00:00 https://pharm-atlas.com/blog/dly-chego-nujny-immunomodulytory/ 2026-02-09T09:09:34+00:00 https://pharm-atlas.com/blog/uhod-za-polostu-rta-vo-vremy-himioterapii/ 2026-02-09T09:06:30+00:00 https://pharm-atlas.com/blog/lecheniye-anemii/ 2026-02-09T09:05:32+00:00 https://pharm-atlas.com/blog/klinicheskie-issledovaniy-onkologicheskih-zabolevaniy-kak-uchastie-v-nih-mojet-pomoch-pa-ientu/ 2026-02-09T08:31:57+00:00 https://pharm-atlas.com/blog/strong-osnovnye-vitaminy-neobhodimye-detym-s-leykozom-strong/ 2026-02-09T08:30:46+00:00 https://pharm-atlas.com/blog/emotsionalnyye-posledstviya-detskoy-onkologii/ 2026-02-09T08:27:20+00:00 https://pharm-atlas.com/blog/dieta-i-obraz-jizni-kotorye-snijaut-risk-razvitiy-jeludochnyh-zabolevaniy/ 2026-02-09T08:25:28+00:00 https://pharm-atlas.com/blog/kak-opredelit-bakterialnye-infek-ii-kotorye-mogut-potrebovat-vmeshatelstva-antibiotikov/ 2026-02-09T08:22:34+00:00 https://pharm-atlas.com/blog/polza-i-vred-obezbolivauschih-preparatov/ 2026-02-06T07:46:00+00:00 https://pharm-atlas.com/blog/pyt-sposobov-uvelichit-vyrabotku-jeludochnoy-kisloty/ 2026-02-06T07:43:26+00:00 https://pharm-atlas.com/blog/produkty-dlya-uluchsheniya-pishchevareniya/ 2026-02-06T07:34:53+00:00 https://pharm-atlas.com/blog/pyat-sovetov-po-zashchite-ot-solnca/ 2026-02-06T07:32:21+00:00 https://pharm-atlas.com/blog/terapiya-onkologii-vidy-i-sposoby-lecheniya/ 2026-02-06T07:29:56+00:00 https://pharm-atlas.com/blog/lekarstvennay-terapiy-onkologii/ 2026-02-06T07:29:19+00:00 https://pharm-atlas.com/blog/kak-stress-vliyayet-na-kozhnyye-zabolevaniya/ 2026-02-06T07:28:41+00:00 https://pharm-atlas.com/blog/lecheniye-onkologii-podkhody-metody-plyusy-minusy/ 2026-02-06T07:25:53+00:00 https://pharm-atlas.com/blog/epilepsiya-sekrety-uspeshnoy-adaptatsii-i-samopomoshchi/ 2026-02-06T07:24:34+00:00 https://pharm-atlas.com/blog/preimushchestva-i-riski-pri-priyome-etodolaka/ 2026-02-06T07:23:25+00:00 https://pharm-atlas.com/blog/populyrnye-preparaty-dly-podavleniy-appetita/ 2026-02-06T07:22:21+00:00 https://pharm-atlas.com/blog/rol-immunomodulytorov-v-podderjanii-zdorovy/ 2026-02-06T07:20:52+00:00 https://pharm-atlas.com/blog/preodolenie-trudnostey-pri-vybore-pravilnyh-preparatov-i-dozirovok-dly-lecheniy-onkologii/ 2026-02-06T07:19:31+00:00 https://pharm-atlas.com/blog/unikalnye-svoystva-trodelvy-i-ego-jeffektivnost-protiv-raka/ 2026-02-05T08:41:59+00:00 https://pharm-atlas.com/blog/effektivnost-i-bezopasnost-keliksa-v-terapii/ 2026-02-05T08:39:17+00:00 https://pharm-atlas.com/blog/diagnostika-i-lecheniye-epilepsii-u-detey/ 2026-02-05T08:34:48+00:00 https://pharm-atlas.com/blog/metody-lecheniya-golovnoy-boli/ 2026-02-05T08:29:24+00:00 https://pharm-atlas.com/blog/priem-vitamina-d-deystvie-vitamina-rekomenda-ii/ 2026-02-05T08:27:23+00:00 https://pharm-atlas.com/blog/rol-antioksidantnyh-vitaminov-s-i-e-rekomenda-ii-po-priemu-i-vliynie-na-organizm/ 2026-02-05T08:26:49+00:00 https://pharm-atlas.com/blog/sredstva-dlya-podavleniya-appetita/ 2026-02-05T08:26:09+00:00 https://pharm-atlas.com/blog/sinteticheskie-i-naturalnye-immunomodulytory-kakie-jeffektivnee-i-bezopasnee-mojno-li-sochetat/ 2026-02-05T08:23:59+00:00 https://pharm-atlas.com/blog/prirodnye-dostupnye-immunostimulytory/ 2026-02-05T08:23:18+00:00 https://pharm-atlas.com/blog/fizicheskaya-aktivnost-i-muzhskoye-zdorovye/ 2026-02-05T08:21:35+00:00 https://pharm-atlas.com/blog/virus-vpch-chto-jeto-takoe-i-kak-on-vliyet-na-organizm-cheloveka/ 2026-02-05T08:17:43+00:00 https://pharm-atlas.com/blog/pravila-priema-pischi-pri-gipotireoze-rekomenda-ii-po-diete-ogranicheniy/ 2026-02-05T08:16:45+00:00 https://pharm-atlas.com/blog/prostatit-u-muzhchin-simptomy-i-sposoby-lecheniya/ 2026-02-05T08:08:56+00:00 https://pharm-atlas.com/blog/insult-i-yego-prichiny-kak-reagirovat-i-kak-ne-dopuskat/ 2026-02-05T08:03:55+00:00 https://pharm-atlas.com/blog/defi-it-immunnoy-reak-ii-vliynie-na-sostoynie-krovi-i-metody-lecheniy/ 2026-02-05T08:00:01+00:00